Trending: Johnson & Johnson and Merck & Co. Announce Acquisitions
08 Janeiro 2024 - 4:54PM
Dow Jones News
1422 ET -- Johnson & Johnson and Merck & Co. are two of
the most mentioned companies in the U.S. across all news items in
the last 12 hours, according to Factiva data. J&J will acquire
Ambrx Biopharma in a deal with a total equity value of about $2
billion. Merck agreed to buy Harpoon Therapeutics for about $680
million. In both transactions, the per-share deal value is more
than twice the Friday closing price. Dow Jones & Co. owns
Factiva. (josh.beckerman@wsj.com)
(END) Dow Jones Newswires
January 08, 2024 14:39 ET (19:39 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Ambrx Biopharma (NASDAQ:AMAM)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Ambrx Biopharma (NASDAQ:AMAM)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024